Suspension of trading
Finanzielle Vergleiche Centessa Pharmaceuticals plc
Aktien
A3CQ72
US1523091007
CNTA
Biotechnologie
|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 24.06. | Swiss Market Index setzt Rally fort; Aktien von OC Oerlikon legen zu | MT |
| 24.06. | Eli Lilly schließt Übernahme von Centessa Pharmaceuticals ab | MT |
Hauptkonkurrenten
| Umsatz (Y-1) | Nettogewinn (Y-1) | EBIT-Marge (Y-1) | ROE (Y-1) | ROA (Y-1) | Verschuldungsgrad (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 15 Mio. | -1’316.88% | -1’384.61% | -42.55% | - | 0.92x | |
| 8.24 Mrd. | 14.53% | 21.7% | 10.28% | 4.9% | 1.58x | |
| 16.31 Mrd. | 8.34% | 13.38% | 32.9% | 4.79% | 3.63x | |
| 5.34 Mrd. | 5.37% | 8.37% | 29.84% | 16.27% | -5.99x | |
| 2.88 Mrd. | 24.74% | 28.07% | 5.94% | 4.75% | 1.77x | |
| 846 Mio. | -31.67% | -18.92% | - | - | 1.57x | |
| 2.53 Mrd. | 17.83% | 20.93% | 70.23% | 22.13% | -0.89x | |
| 944 Mio. | -40.36% | -40.47% | -70.72% | -11.67% | 4.51x | |
| 8.57 Mrd. | 6.51% | 14.79% | 9.61% | 4.34% | 2.22x | |
| 8.25 Mrd. | 2.78% | 16.66% | 10.62% | 6.02% | 1.8x | |
| 5.4 Mio. | -7’306.52% | -5’350% | -135.58% | - | 2.1x | |
| 1.22 Mrd. | 6.02% | 31.45% | 15.37% | 11.65% | 0.43x | |
| 4.02 Mrd. | -3.59% | 19.77% | 15.46% | 6.99% | 1.98x | |
| 1.27 Mrd. | -19.27% | -3.71% | -38.64% | -6.61% | -65.61x | |
| 39.21 Mio. | -794.04% | -891.07% | -25.78% | -22.89% | 4.75x | |
| 1.48 Mrd. | 16.37% | 17.21% | 14.72% | 10.64% | -2.06x | |
| 46.02 Mio. | -282.83% | -343.63% | -20.18% | -18.42% | 0.82x | |
| Durchschnitt | 3.65 Mrd. | -570.16% | -461.18% | -7.4% | 2.35% | -2.73x | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 5.49 Mrd. | -358.65% | -278.02% | 4.09% | 4.95% | -1.58x |
- Börse
- Aktien
- A3CQ72 Aktie
- Sektor Centessa Pharmaceuticals plc
- Finanzielle Vergleiche
Wählen Sie MarketScreener Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben